This system has develop into an essential pillar within the European enterprise financing panorama to promote R&D tasks of fast-growing firms from sectors comparable to ICT, deep tech, and life sciences.
Beginning in 2015, the EIB has supported over 71 life sciences offers with their debt financing packages, offering a complete funding quantity of EUR 1.6bn over its lifetime.
As this system got here to an finish in 2021, the EIB has financed a document of 19 life sciences firms in its final yr with a complete funding quantity of EUR 327m.